Cartesian Therapeutics eliminates CSO role, terminates Dr. Christopher Jewell effective Nov 14, 2025

Cartesian Therapeutics, Inc.

CSO position eliminated; Dr. Christopher Jewell terminated without cause effective November 14, 2025.
Separation agreement signed Oct 20, 2025 provides 12 months salary and pro-rated bonus eligibility.
Dr. Jewell releases all claims against the company in exchange for severance benefits.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001453687-25-000106
form_type: 8-K
ticker: RNAC
cik: 0001453687
company_name: Cartesian Therapeutics, Inc.
filed_at: 2025-10-21T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.444015+00:00
generated_at: 2026-05-17T02:59:53.516977+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: negative
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001453687-25-000106
json_url: https://secwatch.observer/filing/0001453687-25-000106.json
markdown_url: https://secwatch.observer/filing/0001453687-25-000106.md
text_url: https://secwatch.observer/filing/0001453687-25-000106.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000106/0001453687-25-000106-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000106/rnac-20251015.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001453687-25-000106

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.